Long-term efficacy of dupilumab in patients with moderate-to-severe type 2 inflammation by age of asthma onset: LIBERTY ASTHMA TRAVERSE study

被引：0
|
作者：
Busse, William W. [1 ]
Kraft, Monica [2 ]
Domingo, Christian [3 ]
de Mir, Ines [4 ]
Maselli, Diego [5 ]
Xia, Changming [6 ]
Pandit-Abid, Nami [7 ]
Soler, Xavier [8 ]
Jacob-Nara, Juby A. [9 ]
Sacks, Harry [10 ]
Rowe, Paul J. [11 ]
Deniz, Yamo [12 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, UW Allergy Pulm & Crit Care Med, Madison, WI 53706 USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Univ Autonoma Barcelona, Pulm Serv, Barcelona, Spain
[4] Hosp Valle De Hebron, Pulm Funct Lab, Barcelona, Spain
[5] UT Hlth, San Antonio, TX USA
[6] Regeneron Pharmaceut Inc, Stat, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[7] Sanofi, Global Med Affairs, Bridgewater, MA USA
[8] Regeneron Pharmaceut Inc, Dept Med, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[9] Sanofi, Global Med Affairs Resp Allergy & Gastroenterol, Bridgewater, MA USA
[10] Regeneron Pharmaceut Inc, Immunol & Inflammat, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[11] Sanofi, Global Med, Immunol, Bridgewater, MA USA
[12] Regeneron Pharmaceut Inc, Global Clin Dev, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO01-1
引用
收藏
页码：11 / 12
页数：2
相关论文
共 50 条
  • [21] Dupilumab efficacy in adolescents with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUEST
    Maspero, Jorge F.
    FitzGerald, John Mark
    Pavord, Ian D.
    Rice, Megan S.
    Maroni, Jaman
    Rowe, Paul J.
    Pirozzi, Gianluca
    Amin, Nikhil
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    Hardin, Megan
    ALLERGY, 2021, 76 (08) : 2621 - 2624
  • [22] Dupilumab long term efficacy in children with moderate-to-severe type 2 asthma with/without evidence of allergic asthma
    Phipatanakul, W.
    Prenzel, F.
    Papadopoulos, N. G.
    Bacharier, L. B.
    Hamelmann, E.
    Fiocchi, A. G.
    Altincatal, A.
    Gall, R.
    Ledanois, O.
    KLINISCHE PADIATRIE, 2024, 236 (02): : S3 - S4
  • [23] LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN PATIENTS WITH ASTHMA: LIBERTY ASTHMA TRAVERSE OPEN-LABEL EXTENSION STUDY
    Pavord, Id
    Wechsler, Me
    Domingo, C.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Mao, X.
    Kapoor, U.
    Khokhar, Fa
    Mannent, Lp
    Ruddy, M.
    Laws, E.
    Amin, N.
    Hardin, M.
    THORAX, 2021, 76 : A81 - A82
  • [24] DUPILUMAB REDUCED EXACERBATIONS AND IMPROVED LUNG FUNCTIONS IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA AND PRIOR EXACERBATIONS: LIBERTY ASTHMA TRAVERSE STUDY
    Corren, Jonathan
    Castro, Mario
    Maspero, Jorge F.
    Humbert, Marc
    Halpin, David M. G.
    Altincatal, Arman
    Pandit-Abid, Nami
    Soler, Xavier
    Siddiqui, Shahid
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    CHEST, 2022, 162 (04) : 1936A - 1938A
  • [25] Dupilumab Shows Sustained Efficacy and Improvements in Asthma Control and Health-Related Quality of Life in Patients with Moderate-to-Severe Asthma: LIBERTY ASTHMA TRAVERSE
    Wechsler, M.
    Ford, L. B.
    Maspero, J. F.
    Pavord, I. D.
    Langton, D.
    Domingo, C.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Mao, X.
    Amin, N.
    Hardin, M. E.
    Zhang, Y.
    Khan, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [26] Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST
    Wenzel, S. E.
    Pavord, I.
    Zhang, B.
    Maroni, J.
    Rowe, P.
    Hamilton, J. D.
    Swanson, B. N.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [27] Dupilumab Efficacy in LIBERTY ASTHMA QUEST Patients With Uncontrolled, Moderate-to-Severe Asthma By Allergen Sensitization Status
    Corren, Jonathan
    Jackson, David
    Casale, Thomas
    Borish, Larry
    Rabe, Klaus
    Busse, William
    Maspero, Jorge
    Jackson, Daniel
    Daizadeh, Nadia
    Ortiz, Benjamin
    Jacob-Nara, Juby
    Khodzhayev, Angela
    Rowe, Paul
    Djandji, Michel
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB15 - AB15
  • [28] LIBERTY ASTHMA TRAVERSE DUPILUMAB SHOWS SUSTAINED EFFICACY AND IMPROVEMENTS IN ASTHMA CONTROL AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA
    Wechsler, M.
    Ford, L. B.
    Maspero, J. F.
    Pavord, I. D.
    Langton, D.
    Domingo, C.
    Papi, A.
    Bourdin, A.
    Watz, H.
    Mao, X.
    Amin, N.
    Hardin, M.
    Zhang, Y.
    Khan, A. H.
    VALUE IN HEALTH, 2021, 24 : S14 - S14
  • [29] DUPILUMAB EFFICACY IN UNCONTROLLED, MODERATE-TO-SEVERE ALLERGIC ASTHMA IN THE PHASE 3 LIBERTY ASTHMA QUEST STUDY
    Castro, M.
    Corren, J.
    Hanania, N.
    Pavord, I.
    Quirce, S.
    Thangavelu, K.
    Rice, M.
    O'Riordan, T.
    Maroni, J.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Graham, N.
    Teper, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S8 - S8
  • [30] Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study
    Tohda, Yuji
    Nakamura, Yoichi
    Fujisawa, Takao
    Ebisawa, Motohiro
    Arima, Kazuhiko
    Miyata, Masanori
    Takahashi, Yoshinori
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Patel, Naimish
    Graham, Neil M. H.
    Teper, Ariel
    ALLERGOLOGY INTERNATIONAL, 2020, 69 (04) : 578 - 587
12345